SequelSEC

UNITEDHEALTH GROUP INC UNH

Hospital & Medical Service Plans · CIK 0000731766 · Fiscal year ends 1231 · Insurer

Revenue
$447.57B
Fiscal year ended 2025-12-31
Net income
$12.06B
Fiscal year ended 2025-12-31
Total assets
$309.58B
Fiscal year ended 2025-12-31

UNITEDHEALTH GROUP INC (UNH) reported revenue of $447.57B and net income of $12.06B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from UNITEDHEALTH GROUP INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Hospital & Medical Service Plans.

Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.

Income

UNITEDHEALTH GROUP INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$447.57B$400.28B$371.62B$324.16B$287.60B$257.14B$242.16B$226.25B$201.16B$184.84B
Cost of revenue$50.66B$46.69B$38.77B$33.70B$31.03B$30.74B$28.12B$27.00B$24.11B$24.42B
Gross profit$396.91B$353.58B$332.85B$290.46B$256.56B$226.40B$214.04B$199.25B$177.05B$160.42B
Operating income$18.96B$32.29B$32.36B$28.44B$23.97B$22.40B$19.68B$17.34B$15.21B$12.93B
Net income$12.06B$14.40B$22.38B$20.12B$17.28B$15.40B$13.84B$11.99B$10.56B$7.02B
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 911.00Mshares 929.00Mshares 938.00Mshares 950.00Mshares 956.00Mshares 961.00Mshares 966.00Mshares 983.00Mshares 985.00Mshares 968.00M
Pretax income$14.70B$20.07B$29.11B$26.34B$22.31B$20.74B$17.98B$15.94B$14.02B$11.86B
Income tax expense$1.89B$4.83B$5.97B$5.70B$4.58B$4.97B$3.74B$3.56B$3.20B$4.79B
Diluted EPS$13.23$15.51$23.86$21.18$18.08$16.03$14.33$12.19$10.72$7.25
Selling, general & administrative$59.59B$53.01B$54.63B$47.78B$42.58B$41.70B$35.19B$34.07B$29.56B$28.40B
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

UNITEDHEALTH GROUP INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalents$24.36B$25.31B$25.43B$23.36B$21.38B$16.92B$10.98B$10.87B$11.98B$10.43B
Total assets$309.58B$298.28B$273.72B$245.70B$212.21B$197.29B$173.89B$152.22B$139.06B$122.81B
Current assets$90.58B$85.78B$78.44B$69.07B$61.76B$53.72B$42.63B$38.69B$37.08B$33.88B
Total liabilities$207.88B$195.69B$174.80B$159.36B$135.73B$126.75B$111.73B$95.99B$87.04B$82.62B
Current liabilities$114.90B$103.77B$99.05B$89.24B$78.29B$72.42B$61.78B$53.21B$50.46B$49.25B
Total equity incl. NCI$100.09B$98.27B$94.42B$81.45B$75.04B$68.33B$60.44B$54.32B$49.83B$38.18B
Temporary (mezzanine) equity$1.61B$4.32B$4.50B$4.90B$1.43B$2.21B$1.73B$1.91B$2.19B$2.01B
Inventory$3.30B$3.80B$2.80B$3.50B$2.90BUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$23.02B$22.36B$21.28B$17.68B$14.22B$12.87B$11.82B$11.39B$9.57B$8.15B
Goodwill$110.50B$106.73B$103.73B$93.35B$75.80B$71.34B$65.66B$58.91B$54.56B$47.58B
Long-term debt$72.32B$72.36B$58.26B$54.51B$42.38B$38.65B$36.81B$34.58B$28.84B$25.78B
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

UNITEDHEALTH GROUP INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flow$19.70B$24.20B$29.07B$26.21B$22.34B$22.17B$18.46B$15.71B$13.60B$9.80B
Capital expenditures$3.62B$3.50B$3.39B$2.80B$2.45B$2.05B$2.07B$2.06B$2.02B$1.70B
Investing cash flow-$8.68B-$20.53B-$15.57B-$28.48B-$10.37B-$12.53B-$12.70B-$12.38B-$8.60B-$9.36B
Financing cash flow-$11.64B-$3.51B-$11.53B$4.23B-$7.46B-$3.59B-$5.62B-$4.36B-$3.44B-$1.01B
Net change in cash-$947.00M-$115.00M$2.06B$1.99B$4.45B$5.94B$119.00M-$1.12B$1.55B-$493.00M
Stock-based compensation$971.00M$1.02B$1.06B$925.00M$800.00M$679.00M$697.00M$638.00M$597.00M$485.00M
Common dividends paid$7.92B$7.53B$6.76B$5.99B$5.28B$4.58B$3.93B$3.32B$2.77B$2.26B
Common share repurchases$5.54B$9.00B$8.00B$7.00B$5.00B$4.25B$5.50B$4.50B$1.50B$1.28B
Depreciation & amortization$4.36B$4.10B$3.97B$3.40B$3.10B$2.89B$2.72B$2.43B$2.24B$2.06B

Derived

UNITEDHEALTH GROUP INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flow$16.08B$20.70B$25.68B$23.40B$19.89B$20.12B$16.39B$13.65B$11.57B$8.09B
Gross margin88.7%88.3%89.6%89.6%89.2%88.0%88.4%88.1%88.0%86.8%
Operating margin4.2%8.1%8.7%8.8%8.3%8.7%8.1%7.7%7.6%7.0%
FCF margin3.6%5.2%6.9%7.2%6.9%7.8%6.8%6.0%5.8%4.4%
SBC / revenue0.2%0.3%0.3%0.3%0.3%0.3%0.3%0.3%0.3%0.3%
Current ratio0.79x0.83x0.79x0.77x0.79x0.74x0.69x0.73x0.73x0.69x
Revenue YoY growth11.8%7.7%14.6%12.7%11.8%6.2%7.0%12.5%8.8%Unavailable
Net margin2.7%3.6%6.0%6.2%6.0%6.0%5.7%5.3%5.2%3.8%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue0.8%0.9%0.9%0.9%0.9%0.8%0.9%0.9%1.0%0.9%
Long-term debt / equity0.72xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate12.9%24.1%20.5%21.7%20.5%24.0%20.8%22.3%22.8%40.4%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open UNH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-03-02View SEC filing
10-Q · Filed 2025-10-28View SEC filing
10-Q · Filed 2025-08-11View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

cash flow reconciliationreview2025-12-31

Operating, investing and financing flows differ from the reported change in cash by 355000000, beyond tolerance 196970000.00.